Relates to dihydropyrimidine dehydrogenase deficiency testing
Summary
Requires dihydropyrimidine dehydrogenase deficiency testing prior to fluoropyrmidine or other antimetabolite treatment; requires policies and contracts of insurance to include coverage for dihydropyrimidine dehydrogenase deficiency testing; provides for dihydropyrimidine dehydrogenase deficiency testing under the medical assistance program.
Bill status
in committee
1 of 4 stages cleared
Introduction
Jan 2019
Committee Review
Floor Vote
Governor
Introduced Jan 9, 2019
Last action Jan 8, 2020
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
6
Key actions
0
Committee
5
Jan 8, 2020
Committee
REFERRED TO HEALTH
upper
Jun 20, 2019
Committee
RECOMMITTED TO RULES
upper
Mar 26, 2019
Committee
COMMITTEE DISCHARGED AND COMMITTED TO RULES
upper
Jan 22, 2019
Committee
REPORTED AND COMMITTED TO FINANCE
upper
Jan 9, 2019
Committee
REFERRED TO HEALTH
upper
0 primary · 0 co-sponsors
Sponsors
No sponsor information available.
Ask Maddy
·
AI policy assistant
Ask Maddy about S 984
Scope: NY
Hi! I can help you understand S 984. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline